BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,747,000 | -18.1% | 318,354 | -4.5% | 0.19% | -4.5% |
| Q4 2021 | $46,115,000 | -1.0% | 333,516 | -0.6% | 0.20% | -3.8% |
| Q3 2021 | $46,599,000 | +23.2% | 335,462 | -13.9% | 0.21% | +29.6% |
| Q2 2021 | $37,834,000 | +37.2% | 389,722 | -3.5% | 0.16% | +32.8% |
| Q1 2021 | $27,568,000 | -42.4% | 403,882 | -27.7% | 0.12% | -54.8% |
| Q4 2020 | $47,893,000 | +16.5% | 558,786 | -14.2% | 0.27% | +27.4% |
| Q3 2020 | $41,127,000 | -8.0% | 651,165 | +1.0% | 0.21% | -16.5% |
| Q2 2020 | $44,696,000 | +77.1% | 644,779 | -13.1% | 0.25% | +61.8% |
| Q1 2020 | $25,240,000 | -37.9% | 741,719 | -0.6% | 0.16% | -19.5% |
| Q4 2019 | $40,642,000 | -1.0% | 746,549 | -24.2% | 0.20% | -8.0% |
| Q3 2019 | $41,066,000 | – | 984,335 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |